All Stories

  1. Pharmacokinetics and pharmacodynamics of antibacterial peptide NZX in Staphylococcus aureus mastitis mouse model
  2. Polylactic Glycolic Acid-Mediated Delivery of Plectasin Derivative NZ2114 in Staphylococcus epidermidis Biofilms
  3. Efficiency of NZ2114 on Superficial Pyoderma Infected with Staphylococcus pseudintermedius
  4. Expression and characterization of the new antimicrobial peptide AP138L-arg26 anti Staphylococcus aureus
  5. Plectasin: from evolution to truncation, expression, and better druggability
  6. High-Yield Preparation of American Oyster Defensin (AOD) via a Small and Acidic Fusion Tag and Its Functional Characterization
  7. A cleavable chimeric peptide with targeting and killing domains enhances LPS neutralization and antibacterial properties against multi-drug resistant E. coli
  8. Perspective: A proposal on solutions of modern supply chain construction for lactoferrin
  9. Site Mutation Improves the Expression and Antimicrobial Properties of Fungal Defense
  10. Lactoferrin, a Great Wall of host-defence?
  11. Molecular Modification of Kex2 P1’ Site Enhances Expression and Druggability of Fungal Defensin
  12. Thinking on the Construction of Antimicrobial Peptide Databases: Powerful Tools for the Molecular Design and Screening
  13. Editorial: Community series in antimicrobial peptides: Molecular design, structure function relationship and biosynthesis optimization
  14. D1018 with higher stability and excellent lipopolysaccharide binding affinity has potent anti-bacterial and anti-inflammatory activity
  15. Effects of dietary supplementation of bovine lactoferrin on growth performance, immune function and intestinal health in weaning piglets
  16. Effect of NZ2114 against Streptococcus dysgalactiae biofilms and its application in murine mastitis model
  17. Pharmacokinetics and Pharmacodynamics of Fungal Defensin NZX Against Staphylococcus aureus-Induced Mouse Peritonitis Model
  18. C-terminal mini-PEGylation of a marine peptide N6 had potent antibacterial and anti-inflammatory properties against Escherichia coli and Salmonella strains in vitro and in vivo
  19. The Outer Membrane Proteins and Their Synergy Triggered the Protective Effects against Pathogenic Escherichia coli
  20. Antibacterial peptide NZ2114-loaded hydrogel accelerates Staphylococcus aureus-infected wound healing
  21. In Vitro Pharmacodynamics and Bactericidal Mechanism of Fungal Defensin-Derived Peptides NZX and P2 against Streptococcus agalactiae
  22. Editorial: Antimicrobial Peptides: Molecular Design, Structure-Function Relationship, and Biosynthesis Optimization
  23. Fascaplysin derivatives binding to DNA via unique cationic five-ring coplanar backbone showed potent antimicrobial/antibiofilm activity against MRSA in vitro and in vivo
  24. Resistance response to Arenicin derivatives in Escherichia coli
  25. A study on fungal defensin against multidrug-resistant Clostridium perfringens and its treatment on infected poultry
  26. Fatty acid modified-antimicrobial peptide analogues with potent antimicrobial activity and topical therapeutic efficacy against Staphylococcus hyicus
  27. Design and Pharmacodynamics of Recombinant Fungus Defensin NZL with Improved Activity against Staphylococcus hyicus In Vitro and In Vivo
  28. The Pharmacodynamics Study of Insect Defensin DLP4 Against Toxigenic Staphylococcus hyicus ACCC 61734 in Vitro and Vivo
  29. Design and High Expression of Non-glycosylated Lysostaphins in Pichia pastoris and Their Pharmacodynamic Study
  30. Marine Peptide-N6NH2 and Its Derivative-GUON6NH2 Have Potent Antimicrobial Activity Against Intracellular Edwardsiella tarda in vitro and in vivo
  31. Potent intracellular antibacterial activity of a marine peptide-N6NH2 and its D-enantiomer against multidrug-resistant Aeromonas veronii
  32. A prospective on multiple biological activities of lactoferrin contributing to piglet welfare
  33. A recombinant fungal defensin-like peptide-P2 combats Streptococcus dysgalactiae and biofilms
  34. Dual Antibacterial Activities and Biofilm Eradication of a Marine Peptide-N6NH2 and Its Analogs against Multidrug-Resistant Aeromonas veronii
  35. Improved Stability and Activity of a Marine Peptide-N6NH2 against Edwardsiella tarda and Its Preliminary Application in Fish
  36. A Review on the Use of Antimicrobial Peptides to Combat Porcine Viruses
  37. A critical review of antibiotic resistance in probiotic bacteria
  38. Recent progress of bacterial FtsZ inhibitors with a focus on peptides
  39. Therapeutic potential of a designed CSαβ peptide ID13 in Staphylococcus aureus-induced endometritis of mice
  40. An Enhanced Variant Designed From DLP4 Cationic Peptide Against Staphylococcus aureus CVCC 546
  41. Recombinant of the Staphylococcal Bacteriophage Lysin CHAPk and Its Elimination against Streptococcus agalactiae Biofilms
  42. Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli
  43. A new high-yielding antimicrobial peptide NZX and its antibacterial activity against Staphylococcus hyicus in vitro/vivo
  44. Recent progress in preparation and agricultural application of microcapsules
  45. Synthesis and characterization of calcium phosphorylated inulin complex as a new source of enriched calcium supplement with prebiotic effect in food
  46. Internalization, distribution, and activity of peptide H2 against the intracellular multidrug-resistant bovine mastitis-causing bacterium Staphylococcus aureus
  47. A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms
  48. In vitro/vivo Mechanism of Action of MP1102 With Low/Nonresistance Against Streptococcus suis Type 2 Strain CVCC 3928
  49. Improved Antibacterial Activity of the Marine Peptide N6 against Intracellular Salmonella Typhimurium by Conjugating with the Cell-Penetrating Peptide Tat11 via a Cleavable Linker
  50. Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo
  51. A review of the design and modification of lactoferricins and their derivatives
  52. Recent Advances in Antibacterial and Antiendotoxic Peptides or Proteins from Marine Resources
  53. Improved antibacterial activity of a marine peptide-N2 against intracellular Salmonella typhimurium by conjugating with cell-penetrating peptides-bLFcin 6 /Tat 11
  54. Effective Antimicrobial Activity of Plectasin-Derived Antimicrobial Peptides against Staphylococcus aureus Infection in Mammary Glands
  55. Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus
  56. Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A
  57. Deleting the first disulphide bond in an arenicin derivative enhances its expression in Pichia pastoris
  58. Escherichia coli outer membrane protein F (OmpF): an immunogenic protein induces cross-reactive antibodies against Escherichia coli and Shigella
  59. Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis
  60. Research advances on plectasin and its derivatives as new potential antimicrobial candidates
  61. Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules
  62. Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus
  63. In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models
  64. Research and development on lactoferrin and its derivatives in China from 2011–2015
  65. Combined Systems Approaches Reveal a Multistage Mode of Action of a Marine Antimicrobial Peptide against Pathogenic Escherichia coli and Its Protective Effect against Bacterial Peritonitis and Endotoxemia
  66. Enhancement of Nutritional and Antioxidant Properties of Peanut Meal by Bio-modification with Bacillus licheniformis
  67. Modification and characterization of a new recombinant marine antimicrobial peptide N2
  68. In silico analysis and recombinant expression of BamA protein as a universal vaccine against Escherichia coli in mice
  69. Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C
  70. Paving the way to construct a new vaccine against Escherichia coli from its recombinant outer membrane protein C via a murine model
  71. Multiple copies of the target gene enhances plectasin secretion in Pichia pastoris X-33
  72. Detection of genetically modified crops using multiplex asymmetric polymerase chain reaction and asymmetric hyperbranched rolling circle amplification coupled with reverse dot blot
  73. Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
  74. GAP-initiated constitutive expression of a novel plectasin-derived peptide MP1106 by Pichia pastoris and its activity against Streptococcus suis
  75. In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant Staphylococcus aureus
  76. Recombinant outer membrane protein A induces a protective immune response against Escherichia coli infection in mice
  77. Saccharomyces boulardii prevention of the hepatic injury induced by Salmonella Enteritidis infection
  78. Design and recombination expression of a novel plectasin-derived peptide MP1106 and its properties against Staphylococcus aureus
  79. Biotechnical paving of recombinant enterocin A as the candidate of anti-Listeriaagent
  80. Mechanism of action of the tri-hybrid antimicrobial peptide LHP7 from lactoferricin, HP and plectasin on Staphylococcus aureus
  81. A dual mechanism involved in membrane and nucleic acid disruption of AvBD103b, a new avian defensin from the king penguin, against Salmonella enteritidis CVCC3377
  82. Candidacidal mechanism of the arenicin-3-derived peptide NZ17074 from Arenicola marina
  83. Recombinant production of the antimicrobial peptide NZ17074 inPichia pastorisusing SUMO3 as a fusion partner
  84. Rapid cloning, expression and purification of a novel high-activity alkaline phosphatase with detoxification of lipopolysaccharide
  85. Influence of Different Processing Treatments on the Detectability of Nucleic Acid and Protein Targets in Transgenic Soybean Meal
  86. High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus
  87. Erratum to: Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus
  88. Design, expression and characterization of the hybrid antimicrobial peptide LHP7, connected by a flexible linker, against Staphylococcus and Streptococcus
  89. Detection of the Soybean Allergenic Protein Gly m Bd 28K by an Indirect Enzyme-Linked Immunosorbent Assay
  90. DNA Degradation of Genetically Modified Cottonseed Meal During Feed Processing
  91. Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus
  92. Expression of the soybean allergenic protein P34 in Escherichia coli and its indirect ELISA detection method
  93. Characterization of recombinant plectasin: Solubility, antimicrobial activity and factors that affect its activity
  94. Construction of a reference plasmid molecule containing eight targets for the detection of genetically modified crops